Items where authors include "Venugopal, B."

Article

Rossi, S.H., Choueiri, T.K., Jewett, M. orcid.org/0000-0001-7162-5380 et al. (84 more authors) (2025) What is required to deliver practice-changing neoadjuvant trials in kidney cancer? An international neoadjuvant kidney cancer consortium Delphi study. Annals of Oncology. ISSN 0923-7534

Dobbin, S.J.H. orcid.org/0000-0002-9111-0242, Mangion, K. orcid.org/0000-0002-3505-7440, Berry, C. orcid.org/0000-0002-4547-8636 et al. (15 more authors) (2025) Vascular endothelial growth factor inhibitor-induced cardiotoxicity: prospective multimodality assessment incorporating cardiovascular magnetic resonance imaging. Heart. ISSN 1355-6037

Vasudev, N.S. orcid.org/0000-0001-8470-7481, Ainsworth, G., Brown, S. et al. (24 more authors) (2023) Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM). Journal of Clinical Oncology. ISSN 0732-183X

Vasudev, N.S. orcid.org/0000-0001-8470-7481, Ainsworth, G. orcid.org/0000-0002-9952-8440, Brown, S. orcid.org/0000-0002-7975-7537 et al. (24 more authors) (2023) Standard versus modified ipilimumab, in combination with nivolumab, in advanced renal cell carcinoma: a randomized phase II trial (PRISM). Journal of Clinical Oncology. JCO2300236. ISSN 0732-183X

Dobbin, S.J.H., Mangion, K., Berry, C. et al. (9 more authors) (2020) Cardiotoxicity and myocardial hypoperfusion associated with anti‐vascular endothelial growth factor therapies: prospective cardiac magnetic resonance imaging in patients with cancer. European Journal of Heart Failure, 22 (7). pp. 1276-1277. ISSN 1388-9842